TheEdgeResearch
Home / Stocks / TDSGF

Telo Genomics Corp. (TDSGF)

OTC Healthcare Medical - Diagnostics & Research
$0.03 ▲ +3.23%
Market Cap
$3.2M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.17
52-Wk Range
0.02-0.09
CEO
John Allen Farlinger
Country
CA
Currency
USD

Telo Genomics Corp. is a biotechnology enterprise focused on developing and commercializing sophisticated predictive technologies. Their mission is to enable personalized treatment approaches for patients facing specific health challenges. The company's central offering is a telomere analysis platform, which provides both diagnostic insights and prognostic assessments. This platform leverages liquid biopsies and related innovations, with a particular emphasis on applications within oncology (cancer) and neurological diseases. A flagship product, Telo-MM, is a solution designed to equip healthc…

Open full interactive analysis & DCF →